Affective-emotional problems Mental and Behavioural Disorders
Conditions
Interventions
From the health center, an information letter will be sent to the participants obtained from said randomization, which includes information on the study procedure and contact details of the research u
Sponsors
Instituto de Investigación Sanitaria Aragón
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. People aged 35 to 74 years from Aragón (Spain) 2. Understand spoken and written Spanish 3. Informed consent in writing
Exclusion criteria
Exclusion criteria: 1. Suffering from a terminal illness 2. Being institutionalized at the time of the appointment 3. Suffering from an intellectual disability, dementia, or any serious pathology that may seriously interfere with the patient's participation in the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Current primary outcome measures as of 30/08/2022: 1. Severity of depression measured using the Beck Depression Inventory-II (BDI-II) at baseline and 5 years 2. Severity of depression measured using the PHQ-9 at baseline and 5 years 3. Anxiety level measured using the Generalized Anxiety Disorder-7 (GAD-7) at baseline and 5 years _____ Previous primary outcome measure: Severity of depression measured using the Beck Depression Inventory-II (BDI-II) at baseline and 5 years | — |
Secondary
| Measure | Time frame |
|---|---|
| Current primary outcome measures as of 30/08/2022: 1. Sense of coherence measured using the Sense of Coherence Questionnaire (SOC-13) at baseline and 5 years 2. Self-esteem measured using the Rosenberg Questionnaire at baseline and 5 years 3. Comorbidity with chronic diseases determined according to the International Classification of Diseases, Tenth Revision (ICD-10) at baseline and 5 years 4. Clinic variables (TA, Sat O2 %, BMI, temperature) measured on exploration at baseline and 5 years 5. Analytics (basic biochemistry, hemogram, and coagulation) measured using a complete blood count at baseline and 5 years. 6. Work-family interaction measured using the Work-Family Interaction Questionnaire (SWING) at baseline and 5 years 7. Quality of life in menopausal women measured using the Cervantes Scale at baseline and 5 years 8. The frequency of consumption of substances such as tobacco, alcohol, and narcotic substances measured using an ad hoc questionnaire prepared by the research team at baseline and 5 years 9. Alcohol use disorder measured with the Alcohol Use Disorders Identification Test (AUDIT) questionnaire at baseline and 5 years 10. Pathological gambling measured with the Brief Pathological Gambling Questionnaire (CBJP) at baseline and 5 years 11. Addiction to the use of information and communication technologies measured using the MULTICAGE-TIC Questionnaire at baseline and 5 years 12. Self-efficacy measured with General Self Efficacy Scale-12 (GSES-12) at baseline and 5 years 13. Resilence is measured with Connor–Davidson Resilience Scale (CD-Risc-10) at baseline and 5 years 14. Patient activation measured with Patient Activation Questionnaire (PAM-13) at baseline and 5 years 15. Health literacy measured with Health Literacy Survey European Questionnaire (HLS-EU-Q16) at baseline and 5 years 16. Personality measured with Big Five Inventory-10 (BFI-10) at baseline and 5 years 17. Quality of life measured with European Quality of Life-5 Dimensions Questionnaire | — |
Countries
Spain
Outcome results
None listed